F. Weih

Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. (2008)

Voelcker, V., Gebhardt, C., Averbeck, M., Saalbach, A., Wolf, V., Weih, F., ...

Experimental Dermatology, 17(2007) S.100-07

Coordination between NF-#kB family members p50 and p52 is essential for mediating LT#bR signals in the development and organization of secondary lymphoid tissues. (2006)

Lo, J.C., Basak, S., James, E.S., Quiambo, R.S., Kinsella, M.C., Alegre, M.L., ...

Blood, 107(2006) S.1048-55

Neuronal activation of NF-#kB contributes to cell death in cerebral ischemia. (2005)

Zhang, W., Potrovita, I., Tarabin, V., Herrmann, O., Beer, V., Weih, F., ...

Journal of Cerebral Blood Flow and Metabolism, 25(2005) S.30-40

Classical and alternative NF-#kB pathways in distinct cell types regulate NKT cell development. (2004)

Sivakumar, V., Weih, F.

NF-#kB: Biology and Pathology, 2004 Keystone Symp., Keystone, Colo., January 11-16, 2004

Nuclear factor-#kB contributes to infarction after permanent focal ischemia. (2004)

Nurmi, A., Lindsberg, P.J., Koistinaho, M., Zhang, W., Juettler, E., Karjalainen-Lindsberg, M.L., ...

Stroke, 35(2004) S.987-91

The NF-kappa B subunits p50 and p65, but not p52 and c-Rel mediate acute neurodegeneration in vivo. (2004)

Zhang, W., Paxian, S., Pizzi, M., Weih, F., Schneider, A., Schmid, R.M., ...

45.Frühjahrstagung der Deutschen Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie (DGPT), Mainz, 9.-11.März 2004

Protective role of NF-#kB1 (p50) in experimental pneumococcal meningitis. And Corrigendum. (2004)

Kastenbauer, S., Koedel, U., Weih, F., Ziegler-Heitbrock, L., Pfister, H.W.

European Journal of Pharmacology, 498(2004) S.315-18

Towards dissecting the complexity of the AP-1 (Activator Protein 1) family. (2004)

Unal, R., Weih, F., Schorle, H., Herrlich, P.

Girne

NF-#kB controls the balance between Fas and Tumor Necrosis Factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20. (2003)

Malewicz, M., Zeller, N., Weih, F.

TNF Superfamily Conf.2002, San Diego, Calif., October 30 - November 2, 2002

RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. (2003)

Yilmaz, Z.B., Weih, D.S., Sivakumar, V., Weih, F.

The EMBO Journal, 22(2003) S.121-30

Differential requirement for Rel/nuclear factor #kB family members in natural killer T cell development. (2003)

Sivakumar, V., Hammond, K.J.L., Howells, N., Pfeffer, K., Weih, F.

Journal of Experimental Medicine, 197(2003) S.1613-21

Regulation of secondary lymphoid organ development by the nuclear factor-#kB signal transduction pathway. (2003)

Weih, F., Caamano, J.

Immunological reviews, 195(2003) S.91-105

Differential requirement of Rel/NF-#kB family members in natural killer T cell development. (2003)

Sivakumar, V., Weih, F.

Signal Transduction: Receptors, Mediators and Genes ; 7th Joint Meeting of the Signal Transduction Society, Weimar, 6.-8.November 2003

RelB is required for early Peyer's patch development: differential regulation of p52-RelB heterodimers by lymphotoxin and tumor necrosis factor pathways. (2003)

Yilmaz, Z.B., Weih, D.S., Sivakumar, V., Weih, F.

Signal Transduction: Receptors, Mediators and Genes ; 7th Joint Meeting of the Signal Transduction Society, Weimar, 6.-8.November 2003

NF-#kB controls the balance between Fas and Tumor Necrosis Factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20. (2003)

Malewicz, M., Zeller, N., Yilmaz, B., Weih, F.

Journal of Biological Chemistry, 278(2003) S.32825-833

Direct transcriptional regulation of RelB by 1#a,25-dihydroxyvitamin D§3 and its analogs. Physiologic and therapeutic implications for dendritic cell function. (2003)

Dong, X., Craig, T., Xing, N., Bachmann, L.A., Paya, C.V., Weih, F., ...

Journal of Biological Chemistry, 278(2003) S.49378-85

Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. (2002)

Reichardt, H.M., Tuckermann, J.P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., ...

The EMBO Journal, 20(2001) S.7168-73

Activation of p52-RelB heterodimers downstream of the lymphotoxin #b receptor regulates Peyer's patch development. (2002)

Yilmaz, Z.B., Weih, D.S., Weih, F.

Keystone Symp.'NF-kappaB: Bench to Bedside (B8)', Keystone, Colo., February 25 - March 3, 2002

Activation of p52RelB complexes downstream of the lymphotoxin beta receptor regulates lymphoid organ development. (2002)

Yilmaz, Z.B., Weih, D.S., Vallabhapurapu, S., Weih, F.

EMBL/Salk Conf.on Oncogenes and Growth Control, Heidelberg, April 20-23, 2002

Essentielle Rolle des Rel/NF-#kB Familienmitgliedes RelB bei der Entwicklung lymphoider Organe: spezifische Aktivierung durch den Lymphotoxin-#b-Rezeptor. (2002)

Yilmaz, Z.B., Weih, D.S., Weih, F.

Nachrichten - Forschungszentrum Karlsruhe, 34(2002) S.22-25

Essentielle Rolle des Rel/NF-#kB Familienmitgliedes RelB bei der Entwicklung lymphoider Organe: spezifische Aktivierung durch den Lymphotoxin-#b-Rezeptor. (2002)

Weih, F.

Immunologie Aktuell, 2(2002) S.138-40

Differential requirement for Rel/NF-[#k]B family members in natural killer T cell development. (2002)

Weih, F., Vallabhapurapu, S., Yilmaz, B.

TNF Superfamily Conf.2002, San Diego, Calif., October 30 - November 2, 2002

Nuclear factor-#kB activation is not involved in a MPTP model of Parkinson's disease. (2001)

Teismann, P., Schwaninger, M., Weih, F., Ferger, B.

NeuroReport, 12(2001) S.1049-53

RelB-deficient mice lack VCAM-1-positive cell clusters and Peyer's patches. (2001)

Yilmaz, Z.B., Weih, D.S., Pech, M., Weih, F.

Internat.Symp.NF-#kB: Regulation, Gene Expression and Disease, Gent, B, July 4-8, 2001

RelB in non-hematopoietic cells is required for germinal center and marginal zone formation and proper expression of homing chemokines. (2001)

Weih, D.S., Yilmaz, Z.B., Weih, F.

Internat.Symp.NF-#kB: Regulation, Gene Expression and Disease, Gent, B, July 4-8, 2001

Inhibition of NF-#kB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice. (2001)

Vallabhapurapu, S., Ryseck, R.P., Malewicz, M., Weih, D.S., Weih, F.

Internat.Symp.NF-#kB: Regulation, Gene Expression and Disease, Gent, B, July 4-8, 2001

Impaired formation of osteoclasts from marrow cells from NF-#kB knockout mice. (2001)

Hofstetter, W., Portenier, J., Weih, F.

Bone, 28(2001) S.S162

Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. (2001)

Weih, D.S., Yilmaz, Z.B., Weih, F.

The Journal of Immunology, 167(2001) S.1909-19

Inhibition of NF-#kB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice. (2001)

Vallabhapurapu, S., Ryseck, R.P., Malewicz, M., Weih, D.S., Weih, F.

European Journal of Immunology, 31(2001) S.2612-22

RelB expression in stromal cells is required for marginal zone and germinal center formation. (2000)

Weih, F., Barton, D.

NF#kB regulation and Function: From Basic Research to Drug Development (F2), Tahoe City, Calif., February 22-27, 2000

Crucial role of RelB in nonhematopoietic cells in the establishment of follicular dendridic cell networks and germinal centers. (2000)

Weih, F., Barton, D.

6th Internat.Symp.on Dendritic Cells, Port Douglas, AUS, May 26 - June 1, 2000

Free radicals but not NF-#kB are elevated after MPTP treatment in mice. (2000)

Teismann, P., Schwaninger, M., Weih, F., Ferger, B.

30th Annual Meeting of the Society for Neuroscience, New Orleans, La., November 4-9, 2000

Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. (2000)

Barton, D., Hogenesch, H., Weih, F.

European Journal of Immunology, 30(2000) S.2323-32

MHC class II and CD40 play opposing roles in dendritic cell survival. (2000)

Mc Lellan, A., Heldmann, M., Terbeck, G., Weih, F., Linden, C., Bröcker, E., ...

European Journal of Immunology, 30(2000) S.2612-19

Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. (2000)

Weih, D.S., Hogenesch, H., Weih, F.

Joint Annual Meeting 2000 of the German and Dutch Societies of Immunology, Düsseldorf, November 29 - December 2, 2000

RelB expression in non-hematopoietic cells is required for germinal center and marginal zone formation and normal chemokine expression in spleen. (2000)

Weih, D.S., Yilmaz, Z.B., Weih, F.

Joint Annual Meeting 2000 of the German and Dutch Societies of Immunology, Düsseldorf, November 29 - December 2, 2000

NF-#kB is activated and promotes cell death in focal cerebral ischemia. (1999)

Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., Schwaninger, M.

Nature Medicine, 5(1999) S.554-59

Mice lacking the transcription factor RelB develop skin lesions resembling psoriasis. (1999)

Barton, D., Esch, H.H., Weih, F.

6th Internat.Workshop on Langerhans Cells, New York, N.Y., October 8-10, 1999

Transgene Mausmodelle für Entzündungsreaktionen und Immunschwächen: Die Rolle des Rel/NF-kappaB-Familienmitglieds RelB. (1998)

Weih, F.

Habilitation, Universität Karlsruhe 1998

Ein Mausmodell für Entzündungskrankheiten und Autoimmunreaktionen. (1997)

Weih, F.

Nachrichten - Forschungszentrum Karlsruhe, 29(1997) S.263-68

In vivo monitoring of a cAMP-stimulated DNA-binding activity (1990)

Weih, F, Stewart, AF, Boshart, M, Nitsch, D, Schutz, G